Chemed Co. (CHE) Plans Quarterly Dividend of $0.22
Chemed (NYSE:CHE) declared a quarterly dividend on Friday, August 8th, AnalystRatingsNetwork reports. Stockholders of record on Monday, August 18th will be given a dividend of 0.22 per share on Wednesday, September 3rd. This represents a $0.88 dividend on an annualized basis and a yield of 0.88%.
Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of Chemed from a “neutral” rating to an “outperform” rating in a research note on Monday, July 28th. They now have a $104.00 price target on the stock. On a related note, analysts at RBC Capital raised their price target on shares of Chemed from $74.00 to $96.00 in a research note on Monday, July 28th. Finally, analysts at RBC Capital raised their price target on shares of Chemed from $70.00 to $74.00 in a research note on Tuesday, June 10th. They now have a “sector perform” rating on the stock.
Chemed (NYSE:CHE) traded down 0.39% during mid-day trading on Friday, hitting $99.82. The stock had a trading volume of 70,890 shares. Chemed has a 1-year low of $64.16 and a 1-year high of $103.50. The stock has a 50-day moving average of $96.46 and a 200-day moving average of $88.35. The company has a market cap of $1.726 billion and a P/E ratio of 21.30.
Chemed (NYSE:CHE) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $1.50 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.47 by $0.03. The company had revenue of $360.18 million for the quarter, compared to the consensus estimate of $363.73 million. During the same quarter in the prior year, the company posted $1.44 earnings per share. The company’s quarterly revenue was up .8% on a year-over-year basis. Analysts expect that Chemed will post $5.95 EPS for the current fiscal year.
In other Chemed news, VP Arthur V. Tucker, Jr. unloaded 9,000 shares of Chemed stock on the open market in a transaction dated Friday, July 25th. The stock was sold at an average price of $101.26, for a total transaction of $911,340.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Chemed Corporation (NYSE:CHE) purchases, operates and divests subsidiaries engaged in diverse business activities.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.